Filaggrin loss-of-function mutations do not predict food allergy over and above the risk of food sensitization among infants - 31/10/12

HealthNuts Study Investigators![]()
| Supported by the Australian National Health & Medical Research Council (NHMRC), the Ilhan Food Allergy Foundation, AnaphylaxiStop, and the Victorian Government’s Operational Infrastructure Support Program. K.J.A. is a Viertel Senior Medical Research Fellow, J.A.E. and J.J.K. are supported by an NHMRC Capacity Building Grant in Population Health, and M.C.M., L.C.G., A.J.L., M.W., A.-L.P., and S.C.D. hold NHMRC Awards. H.-T.T.T. is a recipient of a Malaysian Government ASTS Scholarship, and T.D.D. is an Australian Postgraduate Award scholar. |
|
| Disclosure of potential conflict of interest: A. J. Lowe, M. Wake, and A.-L. Ponsonby have been supported by one or more grants from the National Health & Medical Research Council of Australia. M. L. K. Tang receives research support from Phadia. K. J. Allen receives speaker’s fees from Nutricia/Danone, Pfizer, Wyeth, and Abbott. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 130 - N° 5
P. 1211 - novembre 2012 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
